379 related articles for article (PubMed ID: 33803255)
1. Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.
Gradisteanu Pircalabioru G; Corcionivoschi N; Gundogdu O; Chifiriuc MC; Marutescu LG; Ispas B; Savu O
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803255
[TBL] [Abstract][Full Text] [Related]
2. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
3. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
[TBL] [Abstract][Full Text] [Related]
4. Role of Microbiome and Antibiotics in Autoimmune Diseases.
Vangoitsenhoven R; Cresci GAM
Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
6. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
[TBL] [Abstract][Full Text] [Related]
8. Microbiome and diabetes: Where are we now?
Vallianou NG; Stratigou T; Tsagarakis S
Diabetes Res Clin Pract; 2018 Dec; 146():111-118. PubMed ID: 30342053
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of
Marißen J; Haiß A; Meyer C; Van Rossum T; Bünte LM; Frommhold D; Gille C; Goedicke-Fritz S; Göpel W; Hudalla H; Pagel J; Pirr S; Siller B; Viemann D; Vens M; König I; Herting E; Zemlin M; Gehring S; Bork P; Henneke P; Härtel C;
BMJ Open; 2019 Nov; 9(11):e032617. PubMed ID: 31753895
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Type 1 Diabetes.
Han H; Li Y; Fang J; Liu G; Yin J; Li T; Yin Y
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584630
[TBL] [Abstract][Full Text] [Related]
11. Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges.
Mokhtari P; Metos J; Anandh Babu PV
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34101547
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes.
Gavin PG; Mullaney JA; Loo D; Cao KL; Gottlieb PA; Hill MM; Zipris D; Hamilton-Williams EE
Diabetes Care; 2018 Oct; 41(10):2178-2186. PubMed ID: 30100563
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiota in type 1 diabetes: friend or foe?
Gavin PG; Hamilton-Williams EE
Curr Opin Endocrinol Diabetes Obes; 2019 Aug; 26(4):207-212. PubMed ID: 31145129
[TBL] [Abstract][Full Text] [Related]
15. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
Khanna S; Raffals LE
Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
[TBL] [Abstract][Full Text] [Related]
16. Distinctive Microbial Signatures and Gut-Brain Crosstalk in Pediatric Patients with Coeliac Disease and Type 1 Diabetes Mellitus.
Singh P; Rawat A; Al-Jarrah B; Saraswathi S; Gad H; Elawad M; Hussain K; Hendaus MA; Al-Masri W; A Malik R; Al Khodor S; Akobeng AK
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546364
[TBL] [Abstract][Full Text] [Related]
17. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.
Ho J; Reimer RA; Doulla M; Huang C
Trials; 2016 Jul; 17(1):347. PubMed ID: 27456494
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
Serban DE
Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
[TBL] [Abstract][Full Text] [Related]
19. The crucial role of early-life gut microbiota in the development of type 1 diabetes.
Zhou H; Sun L; Zhang S; Zhao X; Gang X; Wang G
Acta Diabetol; 2021 Mar; 58(3):249-265. PubMed ID: 32712802
[TBL] [Abstract][Full Text] [Related]
20. The Human Gut Microbiota.
Harmsen HJ; de Goffau MC
Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
